
Division of Endocrinology, Diabetes & Metabolism Publications
Research conducted by NYU Langone’s Division of Endocrinology, Diabetes, and Metabolism appears in leading academic and medical publications.
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts
Nature medicine. 2023 Sep ; 29:2216-2223
Involvement of the Receptor for Advanced Glycation End Products (RAGE) in high fat-high sugar diet-induced anhedonia in rats
Physiology & behavior. 2023 Aug 23; 271:114337
Cardiac lipid metabolism, mitochondrial function and heart failure
Cardiovascular research. 2023 Aug 19; 119:1905-1914
A randomized clinical trial comparing low-fat with precision nutrition-based diets for weight loss: impact on glycemic variability and HbA1c
American journal of clinical nutrition. 2023 Aug ; 118:443-451
Endothelial cell CD36 regulates membrane ceramide formation, exosome fatty acid transfer and circulating fatty acid levels
Nature communications. 2023 Jul 07; 14:4029
Evidence-Based Dietary Practices to Improve Osteoarthritis Symptoms: An Umbrella Review
Nutrients. 2023 Jul 06; 15:
Pharmacological antagonism of receptor for advanced glycation end products signaling promotes thermogenesis, healthful body mass and composition, and metabolism in mice
Obesity (Silver Spring). 2023 Jul ; 31:1825-1843
Cholesterol efflux pathways hinder KRAS-driven lung tumor progenitor cell expansion
Cell stem cell. 2023 Jun 01; 30:800-817.e9